1. Killer dendritic cells and their potential for cancer immunotherapy

   • Nicolas Larmonier
   • Jennifer Fraszczak
   • Emmanuel Katsanis

   Review 18 July 2009 Pages: 1 - 11

   

2. Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

   • Cristina Garrido
   • Ignacio Algarra
   • Angel M. Garcia-Lora

   Original Article 09 May 2009 Pages: 13 - 26

   

3. Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome

   • Franco Maria Venanzi
   • Massimiliano Petrini
   • Angela Riccobon

   Original Article 07 May 2009 Pages: 27 - 34

   

4. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

   • Evelien L. J. M. Smits
   • Nathalie Cools
   • Viggo F. I. Van Tendeloo

   Original Article 16 May 2009 Pages: 35 - 46

   

5. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice

   • Fuminori Abe
   • Alicia J. Dafferner
   • James E. Talmadge

   Original Article 18 May 2009 Pages: 47 - 62

   

6. New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

   • Vittore Cereda
   • Diane J. Poole
   • Kwong Y. Tsang

   Original Article 04 June 2009 Pages: 63 - 71

   

7. Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

   • Miroslaw J. Szczepanski
   • Marta Szajnik
   • Michael Boyiadzis

   Original Article 13 June 2009 Pages: 73 - 79

   

8. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma

   • Alvaro Lladser
   • Karl Ljungberg
   • Rolf Kiessling

   Original Article 14 June 2009 Pages: 81 - 92

   

9. Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth

   • Pei-he Liang
   • Ke-qin Zhang
   • Feng-shuo Jin

   Original Article 19 June 2009 Pages: 93 - 101

   

10. Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8⁺ cytotoxic, tumor-specific T cells

    • Jacobus J. Bosch
    • Uzoma K. Iheagwara
    • Suzanne Ostrand-Rosenberg

    Original Article 26 June 2009 Pages: 103 - 112

    

11. Identification of a 17β-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide

    • Ronald C. Hendrickson
    • Vito R. Cicinnati
    • Albert B. DeLeo

    Original Article 27 June 2009 Pages: 113 - 124

    

12. Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells

    • Ankit Saxena
    • Ambak Rai
    • Dipendra Kumar Mitra

    Original Article 28 June 2009 Pages: 125 - 135

    

13. Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

    • Vedran Radojcic
    • Karl B. Bezak
    • Leo Luznik

    Original Article 10 July 2009 Pages: 137 - 148

    

14. Calicum microdomains form within neutrophils at the neutrophil–tumor cell synapse: role in antibody-dependent target cell apoptosis

    • Andrea J. Clark
    • Michelle Diamond
    • Howard R. Petty

    Original Article 11 July 2009 Pages: 149 - 159

    

15. Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

    • Lavakumar Karyampudi
    • Christopher J. Krco
    • Keith L. Knutson

    Original Article 21 July 2009 Pages: 161 - 171

    

16. Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancer

    • Clarissa P. C. Gomes
    • Mirna S. Freire
    • Octávio Luiz Franco

    Original Article 23 July 2009 Pages: 173 - 181